Ali Alkan
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
-
- Antibiotic Use and Resistance
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 4
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Filiz Çay Şenler (10 shared papers)Özgür Tanrıverdi (20 shared papers)Hakan Akbulut (8 shared papers)Yüksel Ürün (7 shared papers)Stuart Robert Walker (2 shared papers)Güngör Utkan (6 shared papers)Ahmet DEMİRKAZIK (5 shared papers)Hakan Ergün (1 shared paper)
- Journals
- Supportive Care in Cancer (5 papers)Frontiers in Pharmacology (4 papers)Annals of Oncology (3 papers)Future Oncology (3 papers)Scientific Reports (3 papers)
- Partner nations
- TürkiyeUnited KingdomUnited States
In The Last Decade
Ali Alkan
81 papers receiving 677 citations
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 58
- Applied Microbiology and Biotechnology 19
- Family Practice 11
- Economics and Econometrics 148
- Oncology 97
Countries citing papers authored by Ali Alkan
This map shows the geographic impact of Ali Alkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Alkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Alkan more than expected).
Fields of papers citing papers by Ali Alkan
This network shows the impact of papers produced by Ali Alkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Alkan. The network helps show where Ali Alkan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Alkan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 110 | |
| 2 | 2018 | 88 | |
| 3 | 2016 | 63 | |
| 4 | 2018 | 39 | |
| 5 | 2016 | 26 | |
| 6 | 2016 | 20 | |
| 7 | 2019 | 18 | |
| 8 | 2023 | 18 | |
| 9 | 2023 | 17 | |
| 10 | 2020 | 16 | |
| 11 | 2021 | 15 | |
| 12 | 2014 | 14 | |
| 13 | 2017 | 12 | |
| 14 | 2018 | 12 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 11 | |
| 17 | 2020 | 11 | |
| 18 | 2016 | 10 | |
| 19 | 2016 | 10 | |
| 20 | 2017 | 10 |
About Ali Alkan
Ali Alkan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health, Rheumatology and Surgery, having authored 95 papers that have together received 697 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (6 papers), Pharmaceutical studies and practices (5 papers), HER2/EGFR in Cancer Research (4 papers), Advanced Breast Cancer Therapies (4 papers), Palliative Care and End-of-Life Issues (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Chemotherapy-related skin toxicity (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Geriatrics and Gerontology (58 citations), Applied Microbiology and Biotechnology (19 citations), Family Practice (11 citations), Economics and Econometrics (148 citations) and Oncology (97 citations). Ali Alkan has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Filiz Çay Şenler, Özgür Tanrıverdi, Hakan Akbulut, Yüksel Ürün, Stuart Robert Walker, Güngör Utkan, Ahmet DEMİRKAZIK, Hakan Ergün, Elgin Özkan and Mehtap Honca. Their work appears in journals such as Supportive Care in Cancer, Frontiers in Pharmacology, Annals of Oncology, Future Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.